Skip to main content
Premium Trial:

Request an Annual Quote

New NIH FCOI Regs: What You 'Need to Know'

With less than a year for investigators and institutions to prepare for the August 24, 2012 implementation of National Institutes of Health's new financial conflict of interest rules, Office of Extramural Research's Sally Rockey and her colleagues addressed "what NIH grantees need to know" about those revised regulations in a live Webcast this week. Rockey emphasized NIH OER's commitment to assisting investigators and institutions with the implementation of new financial conflict-of-interest policies throughout the discussion, and said that now is the time to begin preparing such policies.

NIH OER's Diane Dean reviewed the key definitions related the revised FCOI regulations, and said that the meaning of "significant financial interest" is the crux of the matter now, as it was in the 1995 regulation, though the thresholds for reporting such interests have changed.

Institutional responsibilities related to FCOI changed, too. Dean said federally funded institutions must develop management plans for every NIH-funded investigator who has reported financial conflicts, and are required to post certain FCOI information on a publicly accessible Web site or make it available to any requestor within five business days of the inquiry.

John Ellis at OER said that when it comes to implementation, "it's going to take a while to work through the details." Indeed, Rockey added that ultimately, dealing with financial conflicts of interest is a "very case-specific type of activity." She said she's hopeful that the research community will come together to address issues as they arise. At present, "we are collecting best practices, and situations and scenarios institutions are going through," Rockey said, adding: "If there's a particular case you want to work through with us, we'd be happy to help."

Be sure to follow @CareersGW on Twitter for up-to-date dispatches on all things life science careers, and more from this Webcast.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.